Showing 11-15 of 15 results for "".

• TRuE-AD3: Ruxolitinib Cream Safe in Pediatric Atopic Dermatitis Patients
  https://practicaldermatology.com/news/true-ad3-ruxolitinib-cream-safe-pediatric-atopic-dermatitis-patients/2467445/
  Ruxolitinib applied twice daily did not appear to impact hematologic parameters in any clinically meaningful way, according to a new study.  "In two randomized phase 3 studies (TRuE-AD1 and TRuE-AD2) evaluating ruxolitinib (Janus kinase [JAK]1/JAK2 inhibitor) cream in adults and adolescent
• Incyte Taps Dr. Pablo J. Cagnoni for New Leadership Role
  https://practicaldermatology.com/news/incyte-taps-dr-pablo-j-cagnoni-for-new-leadership-role/2461704/
  Pablo J. Cagnoni, MD, is Incyte’s New President and Head of Research & Development, effective June 5, 2023.  In this role and as a member of the Executive Team, Dr. Cagnoni will lead Incyte’s R&D efforts across its portfolio of programs in oncology, hematol
• Hema Sunadram, MD
  https://practicaldermatology.com/profiles/hema-sunadram-md/7N53w8/
• Jennifer Cather, MD
  https://practicaldermatology.com/profiles/jennifer-cather-md/jlnrGL/
  Dr. Cather is medical director at Modern Dermatology in Dallas, Texas and co-director of Cutaneous Lymphoma and Graft vs Host Clinics at Baylor University Medical Center in Dallas. Dr. Cather received her medical degree from the University of Texas Southwestern Medical School at Dallas and served h…
• Lawrence F. Eichenfield, MD
  https://practicaldermatology.com/profiles/lawrence-f-eichenfield-md/LAxP1O/
  Dr. Lawrence F. Eichenfield is Chief of Pediatric and Adolescent Dermatology at Rady Children’s Hospital– San Diego, Vice Chair of the Department of Dermatology, and Professor of Dermatology and Pediatrics at the University of California, San Diego (UCSD) School of Medicine. He received his medical…

• Previous
• 1
• 2
• Next